4 terminated, 2 withdrawn, 1 completed, 1 unknown. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 3, Withdrawn 2, Completed 1, Unknown 1 |
| Phase 3 | 1 | Terminated 1 |
Follow squalamine lactate: new trials by email Literature Review of squalamine lactate trials Research Report on squalamine lactate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) Squalamine Lactate Ophthalmic Solution 0.2% - Diabetic Retinopathy | Phase 2 | Withdrawn | Starr Muscle | 2015-02-01 | 2016-06-01 | |
| Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) Squalamine lactate, Vehicle control - Neovascular Age Related Macular Degeneration | Phase 2 | Completed | Ohr Pharmaceutical Inc. | 142 | 2012-11-01 | 2015-06-12 |
| A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration MSI-1256F (Squalamine Lactate) - Macular Degeneration | Phase 2 | Terminated | Genaera Corporation | 140 | 2006-05-01 | 2007-11-28 |
| A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration Squalamine Lactate - "Wet" Age-Related Macular Degeneration | Phase 3 | Terminated | Genaera Corporation | 2005-06-01 | 2007-11-28 | |
| MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) MSI-1256F (Squalamine Lactate) - Macular Degeneration | Phase 2 | Terminated | Genaera Corporation | 60 | 2004-10-01 | 2008-01-09 |
| A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration MSI-1256F (Squalamine Lactate) - Macular Degeneration | Phase 2 | Terminated | Genaera Corporation | 120 | 2004-08-01 | 2007-11-28 |
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer bicalutamide, leuprolide acetate, squalamine lactate - Prostate Cancer | Phase 2 | Withdrawn | OHSU Knight Cancer Institute | 2002-01-01 | 2012-05-28 | |
| Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer carboplatin, squalamine lactate - Ovarian Cancer | Phase 2 | Unknown | Jonsson Comprehensive Cancer Center | 2001-05-01 | 2013-12-18 |
Macular Degeneration (5) · Carcinoma, Ovarian Epithelial (1) · Diabetic Retinopathy (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1)
Genaera Corporation (4) · Jonsson Comprehensive Cancer Center (1) · OHSU Knight Cancer Institute (1) · Ohr Pharmaceutical Inc. (1) · Starr Muscle (1)
United States (7)
Alexander Eaton, MD (1) · Charles Garcia, MD (1) · Daniel Roth, MD (1) · Glenn Stoller, MD (1) · Linnea Chap, MD (1) · Mitchell Sokoloff, MD, FACS (1) · Nelson Sabates, MD (1) · Phillip Rosenfeld, MD (1) · Randy Katz, MD (1) · Raymond Sjaarda, MD (1) · Steven Rose, MD (1) · Thomas Ciulla, MD (1)